Research Progress on Depression Fatigue

doi:10.12114/j.issn.1007-9572.2019.00.321

Abstract

Abstract: The relationship between fatigue and depression is very complex.As a symptom of depression，fatigue is a common premonitory symptom especially at the first attack of the depression.Fatigue is also a residual symptom of depression which is more prone to become chronic disease than other depressive symptoms and is highly related to patients' work and social function defects.Therefore，paying attention to fatigue of depressive patients has important significance for their clinical treatment，the improvement of their quality of life and the reduction of recurrence rate of depression.This article reviews the definition，clinical manifestation，adverse outcomes，mechanism，diagnosis and treatment of depression fatigue in order to provide a reference for doctors.

Key words: Fatigue, Depressive disorder, Signs and symptoms, Quality of life, Review

摘要： 疲劳感与抑郁症的关系十分复杂，其是抑郁症的一种常见症状；是一种普遍的抑郁症前驱症状，尤其是抑郁症首次发作时；也是抑郁症的一种残留症状，并且比其他抑郁症状更易趋于慢性化，与患者工作和社会功能缺损高度相关。因此，关注抑郁症患者的疲劳感症状对临床治疗抑郁症、改善患者的生活质量及降低复发率具有重要的临床意义。本文就抑郁症相关疲劳感的定义、临床表现、不良后果、产生机制、诊治进展进行综述，以期为广大医生提供参考。

关键词: 疲劳感, 抑郁症, 体征和症状, 生活质量, 综述

LI Miao,WANG Qunsong,JIA Hongxiao. Research Progress on Depression Fatigue　[J]. Chinese General Practice, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.
李苗,王群松,贾竑晓. 抑郁症相关疲劳感的研究进展[J]. 中国全科医学, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.

References

［1］World Health Organization. ICD-10精神与行为障碍分类［M］．范肖东，汪向东，于欣，等，译.北京：人民卫生出版社，1993：97-98.
［2］American Psychiatric Association.Diagnostic and statistical manual of mental disorders［M］．Washington DC：American Psychiatric Association，2013：163-164.
［3］SIU A L，US Preventive Services Task Force（USPSTF），BIBBINS-DOMINGO K，et al．Screening for depression in adults US Preventive Services Task Force recommendation statement［J］．JAMA，2016，315（4）：380-387．DOI：10.1001/jama.2015.18392.
［4］ADDINGTON A M，GALLO J J，FORD D E，et al．Epidemiology of unexplained fatigue and major depression in the community：the baltimore ECA follow-up，1981—1994［J］．Psychol Med，2001，31（6）：1037-1044．DOI：10.1017/s0033291701004214.
［5］ARNOLD L M．Understanding fatigue in major depressive disorder and other medical disorders［J］．Psychosomatics，2008，49（3）：185-190．DOI：10.1176/appi.psy.49.3.185.
［6］NYER M，MISCHOULON D，ALPERT J E，et al．College students with depressive symptoms with and without fatigue：differences in functioning，suicidality，anxiety，and depressive severity［J］．Ann Clin Psychiatry，2015，27（2）：100-108.
［7］TRIVEDI M H，RUSH A J，WISNIEWSKI S R，et al．Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D：implications for clinical practice［J］．Am J Psychiatry，2006，163（1）：28-40．DOI：10.1176/appi.ajp.163.1.28.
［8］GREENBERG P E，FOURNIER A A，SISITSKY T，et al．The economic burden of adults with major depressive disorder in the United States （2005 and 2010）［J］．J Clin Psychiatry，2015，76（2）：155-162．DOI：10.4088/JCP.14m09298.
［9］ROBINSON R L，STEPHENSON J J，DENNEHY E B，et al．The importance of unresolved fatigue in depression：costs and comorbidities［J］．Psychosomatics，2015，56（3）：274-285．DOI：10.1016/j.psym.2014.08.003.
［10］ROBINSON R L，GRABNER M，PALLI S R，et al．Covariates of depression and high utilizers of healthcare：impact on resource use and costs［J］．J Psychosom Res，2016，85：35-43．DOI：10.1016/j.jpsychores.2016.04.002.
［11］STAHL S M，ZHANG L，DAMATARCA C，et al．Brain circuits determine destiny in depression：a novel approach to the psychopharmacology of wakefulness，fatigue，and executive dysfunction in major depressive disorder［J］．J Clin Psychiatry，2003，64（suppl 14）：6-17．DOI：10.1007/S00357-003-0016-2.
［12］FAVA M，BALL S，NELSON J C，et al．Clinical relevance of fatigue as a residual symptom in major depressive disorder［J］．Depress Anxiety，2014，31（3）：250-257．DOI：10.1002/da.22199.
［13］ANISMAN H，MERALI Z，POULTER M O，et al．Cytokines as a precipitant of depressive illness：animal and human studies［J］．Curr Pharm Des，2005，11（8）：963-972．DOI：10.2174/1381612053381701．
［14］SIMON N M，MCNAMARA K，CHOW C W，et al．A detailed examination of cytokine abnormalities in major depressive disorder［J］．Eur Neuropsychopharmacol，2008，18（3）：230-233．DOI：10.1016/j.euroneuro.2007.06.004.
［15］MCCLINTOCK S M，HUSAIN M M，WISNIEWSKI S R，et al．Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication［J］．J Clin Psychopharmacol，2011，31（2）：180-186．DOI：10.1097/jcp.0b013e31820ebd2c.
［16］BALDWIN D S，PAPAKOSTAS G I．Symptoms of fatigue and sleepiness in major depressive disorder［J］．J Clin Psychiatry，2006，67：9-15．DOI：10.1080/13803390590929298.
［17］SCHWEITZER P K．Principles and practice of sleep medicine［M］．6th ed．Philadelphia：PA，2017：480-498.
［18］FERENTINOS P P，KONTAXAKIS V P，HAVAKI-KONTAXAKI B J，et al．The measurement of fatigue in depression［J］．Psychopathology，2007，40（2）：133-134．DOI：10.1159/000098494.
［19］MATZA L S，WYRWICH K W，PHILLIPS G A，et al．The fatigue associated with depression scale：responsiveness and responder definition［J］．Qual Life Res，2013，22（2）：351-360．DOI：10.1007/s11136-012-0142-6.
［20］COOPER J A，TUCKER V L．Resolution of sleepiness and fatigue：a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union［J］．J Psychopharmacol，2014，28（2）：118-124．DOI：10.1177/0269881113514878.
［21］DEBATTISTA C，DOGHRAMJI K，MENZA M A，et al．Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder：a preliminary doubleblind placebo-controlled study［J］．J Clin Psychiatry，2003，64（9）：1057-1064．DOI：10.1111/1469-7610.00176_12.
［22］FAVA M，THASE M E，DEBATTISTA C．A multicenter，placebocontrolled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness［J］．J Clin Psychiatry，2005，66（1）：85-93．DOI：10.0000/PMID15669893.

[1]	CUI Yiyuan, YAN Yijing, WANG Ying, MENG Xiangju, ZHANG Qinglin, LIU Lixing, LI Sicong, FENG Li, The Working Group for the Clinical Practice Guideline for the Cancer-related Fatigue with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Cancer-related Fatigue [J]. Chinese General Practice, 2025, 28(27): 3345-3358.
[2]	HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258.
[3]	WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914.
[4]	XU Yisha, LI Chunmei, WANG Chengcheng, GUO Wei, GAN Yunong, ZHANG Yu, ZHANG Wen, YU Congcong. Characterization of Intestinal Flora in Different Age Groups with Chronic Fatigue Syndrome [J]. Chinese General Practice, 2025, 28(23): 2900-2907.
[5]	WEN Min, ZHOU Yongling, LIU Jingjing, JIANG Keqing, LIU Juan, ZHU Xiaodan. The Effect and Mechanism of Compensatory Cognitive Training Based on mHealth APP on Stable Schizophrenia Patients [J]. Chinese General Practice, 2025, 28(22): 2819-2825.
[6]	YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818.
[7]	ZHANG Qi, HE Shen, LI Hua. Interpretation of Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement 2022 [J]. Chinese General Practice, 2025, 28(15): 1823-1830.
[8]	YUE Xiao, WANG Mei. Analysis of Age-related Changes of Characteristics and High Frequency Symptoms in Pre-elderly and Elderly Inpatients [J]. Chinese General Practice, 2025, 28(12): 1439-1445.
[9]	FAN Jianing, CHEN Jieting, WANG Ziqi, FAN Jinhe, JING Mingxia. Analysis of the Development Trajectory of Health-related Quality of Life in Middle-aged and Elderly Patients with Cardiometabolic Diseases and the Influencing Factors [J]. Chinese General Practice, 2025, 28(08): 923-932.
[10]	YAO Dingye, LUO Guiping, SUN Junsheng, REN Jingjing. Diagnosis and Treatment of Halitosis: a General Practice Perspective [J]. Chinese General Practice, 2025, 28(07): 900-904.
[11]	YANG Ling, DU Xueping. Application of Murtagh Safe Diagnostic Strategy Combined with Mind Mapping for Establishing Clinical Thinking in General Practice Teaching Clinic [J]. Chinese General Practice, 2025, 28(06): 673-680.
[12]	FAN Haojie, LIU Lewei, XIA Lei, TIAN Yinghan, YANG Cheng, HAO Mingru, ZHAO Xin, SHEN Qingqing, MO Daming, GENG Feng, LIU Huanzhong. Correlation of Non-suicidal Self-injury with 25-Hydroxyvitamin D₃ and Blood Lipid Levels in Adolescents with Major Depressive Disorder [J]. Chinese General Practice, 2025, 28(05): 612-618.
[13]	LI Hongmei, ZHANG Yimin, WANG Yong, ZHANG Yurong, JIA Xiao, YU Jingjing, SANG Die. Aerobic Exercise Improves Physique and Quality of Life in Breast Cancer Patients During Anthracycline-based Chemotherapy: a Randomized Controlled Trial [J]. Chinese General Practice, 2025, 28(03): 285-292.
[14]	QI Mingrui, WANG Wenjuan, TIAN Limin. Health-related Quality of Life of Elderly Hypertensive Population in Northwest China [J]. Chinese General Practice, 2025, 28(02): 199-207.
[15]	FENG Caixia, WANG Zengshuai, MU Hailin, YANG Hanxuan, TAMIR. Effect of Parkinson's Disease Management Model Dominated by Movement Disorder Specialists and Centered on Community Doctors [J]. Chinese General Practice, 2024, 27(34): 4280-4285.